← FDA Drug Approvals (Drugs@FDA)

METHIMAZOLE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: BIONPHARMA · Approved 2023-09-25

Drug application

FDA Application #

ANDA218149

Application type

Abbreviated New Drug Application (Generic)

Brand name

METHIMAZOLE

Generic name

METHIMAZOLE

Active ingredients

METHIMAZOLE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

BIONPHARMA

Manufacturer

Bionpharma Inc.

First approval

2023-09-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown